Global Cancer Generics Market Insights and Forecast to 2022
Summary –
A new
market study, “Global Cancer Generics Market Insights and Forecast
to 2022 “has been featured on
WiseGuyReports.
Within
the pharmaceutical industry, the oncology market is growing at a rapid pace
owing to the rising incidences of cancer. In 2015, 15.2 Million new cancer
cases were registered across the globe. This number is forecasted to increase
to a value of 19.3 Million by 2025. Furthermore, the patent expiry of
blockbuster cancer drugs is another major factor which is propelling the growth
of the cancer generics industry.
As per RNCOS report “Global Cancer Generics
Market Forecast to 2022”, the global cancer generics market is anticipated to
witness a double digit growth during 2016-2022. This report provides a detailed
analysis of the current and future market scenario of the global cancer
generics market. The report provides insight about the major drivers and
challenges, along with the latest trends and developments impacting the
industry growth. In addition, the report also highlights various opportunities
available for growth of the global cancer generics market.
The global cancer generics market has been
segmented on the basis of mode of administration into oral and injectables.
Injectables are the most widely used type of cancer generics drugs. The report
also highlights the major cancer generic drugs available in the global market.
Furthermore, the global cancer generics market
has also been segmented on the basis of the major indications they are used
for. According to the report, breast cancer is expected to account for the
largest share in 2016 due to presence of large number of generic drugs and
rising incidences of this indication.
Based on geography, the report divides market
into North America, Europe, and Asia-Pacific. In 2016, North America is
estimated to account for the largest share. Moreover, the report also lists
down various mergers and acquisitions taking place in the global generics
industry.
The last section of the report discusses about
the prominent players in global cancer generics market. A brief business
overview and financial information about each of these players has been
provided, along with their product portfolios. The recent development of every
player has also been presented in the report. Overall, the research contains
exhaustive information that will help clients in formulating market strategies
and assessing opportunity areas in the global cancer generics market
FOR MORE DETAILS: https://www.wiseguyreports.com/reports/1706470-global-cancer-generics-market-forecast-to-2022
About Us:
Wise Guy Reports is part of the Wise Guy Research
Consultants Pvt. Ltd. and offers premium progressive statistical surveying,
market research reports, analysis & forecast data for industries and
governments around the globe.
Contact Us:
NORAH TRENT
Ph: +162-825-80070 (US)
Ph: +44 2035002763 (UK)
Comments
Post a Comment